2026-01-23 - Analysis Report
### Financial Report

#### Company Overview
Northrop Grumman is a leading provider of cybersecurity and information technology solutions.

#### Return Rate Comparison

* Ticker to review: NOC
* Cumulative return of review stock: 60.93%
* Cumulative return of comparison stock (S&P 500, VOO): 92.53%
* Divergence: -31.60
* Relative divergence: 26.20%

The return rate of Northrop Grumman (NOC) is lower than the S&P 500, indicating a higher level of risk compared to the broader market.

#### Alpha, Beta Analysis

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -6.0% | 23.7% | -11.0% | 0.7 | 35.1B |
| 2017-2019  | 15.0% | 23.7% | -2.0% | 0.7 | 49.2B |
| 2018-2020  | -25.0% | 23.7% | -46.0% | 0.8 | 43.6B |
| 2019-2021  | 40.0% | 12.9% | -3.0% | 0.7 | 55.4B |
| 2020-2022  | 18.0% | 16.9% | 19.0% | 0.6 | 78.1B |
| 2021-2023  | 23.0% | 16.9% | 22.0% | 0.3 | 67.0B |
| 2022-2024  | -14.0% | 16.9% | -33.0% | 0.3 | 67.2B |
| 2023-2025  | -1.0% | 17.7% | -63.0% | 0.1 | 81.6B |

* Northrop Grumman has experienced high volatility in the past, with a high maximum drawdown.
* The CAGR (Compound Annual Growth Rate) is relatively stable, indicating a consistent long-term growth.
* Beta is generally stable, indicating a consistent level of market risk.

#### Recent Stock Price Fluctuations

* Recent prices: 
    + $670.44 (Close)
    + $664.16 (Previous Close)
    + $0.95 (Change)
* Moving averages:
    + 5-day SMA: $662.68
    + 20-day SMA: $613.90
    + 60-day SMA: $582.43

The current stock price is near the 20-day SMA, indicating a consolidation phase.

#### RSI, PPO Analysis

* Market Risk Indicator (MRI): 0.90
* RSI: 75.61
* PPO: 0.97
* Hybrid Signal: Buy (Cash 0%)
Risk Level: High (MRI 0.90)
* Recent (20 days) relative divergence change: 10.80 (+)
* 7-day Rank change: 36 (+)
* 7-day Dynamic Expected Return change: 10.40 (+)

* The MRI is high, indicating a high level of market risk.
* The RSI is above 70, indicating a high level of momentum.
* The PPO is above 1, indicating a bullish trend.
* The hybrid signal is buying.

#### Recent News & Significant Events

* [2026-01-08] Whatâ€™s The Risk For Northrop Grumman Stock As Trump Curbs Dividends And Executive Pay?
* [2026-01-21] Northrop Grumman Corporation (NOC) a Moderate Buy, Analysts See 4% Upside
* [2026-01-20] Lobbying Update: $1,830,000 of NORTHROP GRUMMAN CORPORATION lobbying was just disclosed
* [2026-01-08] Stocks making the biggest moves premarket: Lockheed Martin, Northrop Grumman, Gap, Alcoa & more
* [2026-01-20] Northrop Grumman (NOC) Projected to Post Quarterly Earnings on Tuesday
* [2026-01-06] Northrop Grumman Rising Toward New High With Fourth Quarter Earnings Up Next

#### Analyst Opinions

* Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
  - Opinions: 21
  - Target Price (avg/high/low): 675.63 / 777.00 / 576.00

The analysts' consensus is to buy the stock, with a relatively low target price.

#### Recent Earnings Analysis

| Date | EPS | Revenue |
|-----|----:|---------|
| 2025-10-21 | 7.69 | 10.42 B$ |
| 2025-07-22 | 8.17 | 10.35 B$ |
| 2025-04-22 | 3.33 | 9.47 B$ |
| 2024-10-24 | 7.02 | 10.00 B$ |
| 2025-10-21 | 7.02 | 10.00 B$ |

The company has experienced significant revenue growth in recent quarters.

#### Financial Information

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $10.42B | 21.37% |
| 2025-06-30 | $10.35B | 21.35% |
| 2025-03-31 | $9.47B | 16.69% |
| 2024-12-31 | $10.69B | 18.08% |
| 2024-09-30 | $10.00B | 21.07% |

The company has maintained high profit margins in recent quarters.

### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $15.99B | 6.88% |
| 2025-06-30 | $15.47B | 7.59% |
| 2025-03-31 | $14.98B | 3.21% |
| 2024-12-31 | $15.29B | 8.27% |
| 2024-09-30 | $14.75B | 6.96% |

The company has experienced significant growth in equity, but return on equity (ROE) has been relatively stable.

### Comprehensive Analysis

Northrop Grumman has experienced high volatility in the past, but the current stock price is near the 20-day SMA, indicating a consolidation phase. The analysts' consensus is to buy the stock, but the target price is relatively low. The company has maintained high profit margins in recent quarters, and equity has grown significantly.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.